Smilaffe Tablets 50mg

Smilaffe Tablets 50mg, containing Peficitinib hydrobromide, is manufactured by Astellas Pharma (YJ code: 3999046F1023, standard: 50mg 1 tablet). Peficitinib is a Janus kinase (JAK) inhibitor used for the treatment of moderate to severe rheumatoid arthritis, particularly in adult patients who have not responded adequately to conventional therapies. It works by inhibiting JAK enzymes to reduce inflammation.